1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
33.96%
Revenue growth above 1.5x ENPH's 1.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-13.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
3.34%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
3.34%
Operating income growth under 50% of ENPH's 26.34%. Michael Burry would be concerned about deeper cost or sales issues.
60.74%
Net income growth above 1.5x ENPH's 24.63%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
34.50%
EPS growth above 1.5x ENPH's 21.74%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
34.50%
Diluted EPS growth above 1.5x ENPH's 22.73%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-16.12%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-16.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-100.51%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-188.03%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
1468.44%
10Y revenue/share CAGR above 1.5x ENPH's 20.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1468.44%
5Y revenue/share CAGR above 1.5x ENPH's 174.77%. David Dodd would look for consistent product or market expansions fueling outperformance.
1468.44%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
84.42%
10Y OCF/share CAGR under 50% of ENPH's 176.50%. Michael Burry would worry about a persistent underperformance in cash creation.
84.42%
Positive OCF/share growth while ENPH is negative. John Neff might see a comparative advantage in operational cash viability.
84.42%
Positive 3Y OCF/share CAGR while ENPH is negative. John Neff might see a big short-term edge in operational efficiency.
80.68%
Below 50% of ENPH's 2178.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
80.68%
Below 50% of ENPH's 174.41%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
80.68%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
42.45%
AR growth well above ENPH's 17.72%. Michael Burry fears inflated revenue or higher default risk in the near future.
26.21%
Inventory growth well above ENPH's 20.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
92.75%
Asset growth above 1.5x ENPH's 2.34%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
250.95%
BV/share growth above 1.5x ENPH's 9.32%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
-59.76%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-183.30%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.